127 related articles for article (PubMed ID: 9387330)
1. [Post-thyroidectomy osteoporosis].
Wang Y; Wu H; Zhou J
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):308-9. PubMed ID: 9387330
[TBL] [Abstract][Full Text] [Related]
2. [Bone tissue mineral density in patients with thyroid gland cancer on levothyroxine natrium therapy].
Khmara IM; Tolkachev IuV
Klin Med (Mosk); 2005; 83(10):61-5. PubMed ID: 16320850
[TBL] [Abstract][Full Text] [Related]
3. Does total thyroidectomy induce metabolic bone disturbance?
Sugino K; Kure Y; Iwasaki H; Matsumoto A
Int Surg; 1992; 77(3):178-80. PubMed ID: 1399364
[TBL] [Abstract][Full Text] [Related]
4. Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy.
Mirzaei S; Krotla G; Knoll P; Koriska K; Köhn H
Acta Med Austriaca; 1999; 26(1):29-31. PubMed ID: 10230474
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
6. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of thyroid hormone and bone metabolism in the rat].
Ding G
Zhonghua Yi Xue Za Zhi; 1990 Apr; 70(4):198-200, 16. PubMed ID: 2167757
[TBL] [Abstract][Full Text] [Related]
8. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin.
Hurley DL; Tiegs RD; Wahner HW; Heath H
N Engl J Med; 1987 Aug; 317(9):537-41. PubMed ID: 3614305
[TBL] [Abstract][Full Text] [Related]
9. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on the treatment of differentiated carcinoma of the thyroid gland].
Francomano F; Napolitano L; De Luca D; Scipione P; Napolitano AM
G Chir; 1999; 20(1-2):31-3. PubMed ID: 10097453
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
Florkowski CM; Brownlie BE; Elliot JR; Ayling EM; Turner JG
N Z Med J; 1993 Oct; 106(966):443-4. PubMed ID: 8233173
[TBL] [Abstract][Full Text] [Related]
12. [Criteria for suppressive dosage of thyroxine administered in thyroid cancer].
Khmara IM; Demidchik IuE; Shapet'ko MN
Vopr Onkol; 2004; 50(5):580-4. PubMed ID: 15715101
[TBL] [Abstract][Full Text] [Related]
13. Androgens and bone mineral content in patients with subtotal thyroidectomy for benign nodular disease.
Lakatos P; Tarján G; Mérei J; Földes J; Holló I
Acta Med Hung; 1989; 46(4):297-305. PubMed ID: 2636363
[TBL] [Abstract][Full Text] [Related]
14. [Papillary carcinoma of the thyroid gland].
Krgović K; Paunović I; Diklić A; Zivaljević V; Tatić S; Havelka M; Todorović-Kazić M; Kalezić N; Bozić V
Acta Chir Iugosl; 2003; 50(3):79-84. PubMed ID: 15179760
[TBL] [Abstract][Full Text] [Related]
15. The comparative study of bone mineral density between premenopausal women receiving long term suppressive doses of levothyroxine for well-differentiated thyroid cancer with healthy premenopausal women.
Sajjinanont T; Rajchadara S; Sriassawaamorn N; Panichkul S
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S71-6. PubMed ID: 16858944
[TBL] [Abstract][Full Text] [Related]
16. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid and calcitropic hormone secretion disorders in thyroid cancer].
Ivanov PK; Telish VM
Med Radiol (Mosk); 1983 Aug; 28(8):51-4. PubMed ID: 6888211
[TBL] [Abstract][Full Text] [Related]
18. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
20. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
